Sign in

CIK 0001841387 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Candel Therapeutics, Inc.

Sign in to watch
Ticker
CADL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
522214851
Phone
617-916-5445
Business address
117 KENDRICK STREET, SUITE 450, NEEDHAM, MA, 02494
  1. 8-K Event Executive or director change
  2. ARS Other Annual Report to Security Holders
  3. DEF 14A Proxy Proxy Statement
  4. 8-K Event Regulation FD disclosure · Other events
  5. 10-Q Report Quarterly Report
  6. 8-K Event Results of operations
  7. 8-K Event Director nominations
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 10-K/A Report 10-K/A
  14. 8-K Event Regulation FD disclosure
  15. S-8 Other Securities Offered to Employees in Benefit Plans
  16. 10-K Report Annual Report
  17. 8-K Event Results of operations
  18. 8-K Event Regulation FD disclosure
  19. 4/A Open-market buy Director bought 27,000 shares at an average $1.89 ($51,108)
  20. SC 13G/A Stake Amended Statement of Ownership

Page 15 of 22 · 422 filings